AC
AGN

Ascend Capital’s Allergan Inc AGN Stock Holding History

Ascend Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-237,521
Closed -$50.5M – 240
2014
Q4 		$50.5M Buy
237,521
+26,093
+12% +$5.19M 1.94% 9
2014
Q3 		$37.7M Buy
211,428
+116,014
+122% +$19.3M 1.11% 27
2014
Q2 		$16.1M Buy
+95,414
New +$14.9M 0.54% 60
2014
Q1 		– Sell
-62,016
Closed -$6.89M – 264
2013
Q4 		$6.89M Sell
62,016
-57,984
-48% -$5.54M 0.21% 123
2013
Q3 		$10.9M Buy
+120,000
New +$10.8M 0.4% 82

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Ascend Capital's AGN Position: Q1 2015 in Review

Ascend Capital sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 237,521 shares — an estimated $50.5M sold.

Ascend Capital first reported a position in AGN in Q3 2013 and held it in 5 quarters. The position peaked at $50.5M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Ascend Capital reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Ascend Capital sold 237,521 Allergan Inc shares in Q1 2015, an estimated $50.5M.
  • Ascend Capital first reported a position in Allergan Inc in Q3 2013 and held it in 5 quarters.
  • Ascend Capital's Allergan Inc position peaked at $50.5M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Ascend Capital's 13F filing for Q1 2015, filed 14 May 2015.